Literature DB >> 22471481

Increased expression of IL-6 mRNA in hepatocellular carcinoma cell lines correlates with biological characteristics.

Fang-Jun Yuan1, You-Shun Zhang, Ying Wei, Can Zou, Long Chen, Ling Huang, Zhishu Liu.   

Abstract

BACKGROUND AND AIMS: IL-6 has been implicated in both virus-associated and diethylnitrosamine-induced hepatocellular carcinomas (HCCs). Generally it is produced by immune cells such as Kupffer cells in the liver. To understand mechanisms by which IL-6 might participate in the genesis of HCCs, the production of IL-6 by cell lines under different conditions was examined to determine inducing factors.
METHODS: Expression of IL-6 mRNA in both hepatoma cell lines and a normal liver cell line L-02 was measured by quantitative RT-PCR. Biological molecules including liposome, dsRNA and cell debris were used to stimulate IL-6 mRNA expression in HepG2 cells and inhibition was effected by RNAi. Proliferation was assessed by MTT and clone formation and migration was determined by scratch assay.
RESULTS: All of the HCC cell lines observed expressed IL-6 mRNA, including HepG2, Bel-7402(7402), MHCC-97H and SMMC-7721.Normal liver cell line L-02 also expressed IL-6 mRNA. SiRNA to IL-6 specifically knockdowned IL-6 mRNA expression in HepG2, and liposome, dsRNA and cell debris increased it. Both proliferation and migration of HepG2 cells were related to the level of IL-6 HepG2 expressed.
CONCLUSION: Both normal liver cell line and HCC cell lines can produce IL-6 so that Kupffer cells are noit the only source of the cytokine in the liver well as other immune cells. That the fact that HCC cells reacted to stimulation of biological molecules such as liposome, dsRNA or cell debris with increasing production of IL-6 indicates that the cytokine might play an important role not only in the period of tumor initiation but progression and recurrence as well.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22471481

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  5 in total

1.  Atorvastatin-induced senescence of hepatocellular carcinoma is mediated by downregulation of hTERT through the suppression of the IL-6/STAT3 pathway.

Authors:  Jeng-Jer Shieh; Chun-Ying Wu; Sin-Ting Wang; Shi-Wei Huang; Kuang-Ting Liu; Teng-Yu Lee
Journal:  Cell Death Discov       Date:  2020-03-30

2.  Physical Activity and Risk of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Kara DiJoseph; Audrey Thorp; Alex Harrington; Kathryn H Schmitz; Vernon M Chinchilli; Jonathan G Stine
Journal:  Dig Dis Sci       Date:  2022-06-29       Impact factor: 3.199

3.  Secretion of interleukin-6 by bone marrow mesenchymal stem cells promotes metastasis in hepatocellular carcinoma.

Authors:  Fei Mi; Liansheng Gong
Journal:  Biosci Rep       Date:  2017-07-21       Impact factor: 3.840

4.  Atorvastatin-induced senescence of hepatocellular carcinoma is mediated by downregulation of hTERT through the suppression of the IL-6/STAT3 pathway.

Authors:  Jeng-Jer Shieh; Chun-Ying Wu; Sin-Ting Wang; Shi-Wei Huang; Kuang-Ting Liu; Teng-Yu Lee
Journal:  Cell Death Discov       Date:  2020-03-30

5.  Silencing CDC25A inhibits the proliferation of liver cancer cells by downregulating IL‑6 in vitro and in vivo.

Authors:  Si Chen; Yanping Tang; Chun Yang; Kezhi Li; Xiaoqing Huang; Ji Cao
Journal:  Int J Mol Med       Date:  2020-01-09       Impact factor: 4.101

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.